Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine‐associated diseases
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
A structure–potency study examining the ability of dopamine (DA), its major metabolites and related amine and acetate congeners to inhibit NADH‐linked mitochondrial O 2 consumption was carried out to elucidate mechanisms by which DA could induce mitochondrial dysfunction. In the amine studies, DA was the most potent inhibitor of respiration (IC 50 7.0 m m) compared with 3‐methoxytryramine (3‐MT, IC 50 19.6 m m), 3,4‐dimethoxyphenylethylamine (IC 50 28.6 m m), tyramine (IC 50 40.3 m m) and phenylethylamine (IC 50 58.7 m m). Addition of monoamine oxidase (MAO) inhibitors afforded nearly complete protection against inhibition by phenylethylamine, tyramine and 3,4‐dimethoxyphenylethylamine, indicating that inhibition arose from MAO‐mediated pathways. In contrast, the inhibitory effects of DA and 3‐MT were only partially prevented by MAO blockade, suggesting that inhibition might also arise from two‐electron catechol oxidation and quinone formation by DA and one‐electron oxidation of the 4‐hydroxyphenyl group of 3‐MT. In the phenylacetate studies, 3,4‐dihydroxyphenylacetic acid (DOPAC) was equipotent with DA in inhibiting respiration (IC 50 7.4 m m), further implicating the catechol reaction as the cause of inhibition. All other carboxylate congeners; phenylacetic acid (IC 50 13.0 m m), 4‐hydroxyphenylacetic acid (IC 50 12.1 m m), 4‐hydroxy‐3‐methoxyphenylacetic acid (HVA, IC 50 12.0 m m) and 3,4‐dimethoxyphenylacetic acid (IC 50 10.2 m m), were equipotent respiratory inhibitors and two‐ to fourfold more potent than their corresponding amine. These latter findings suggest that the phenylacetate ion can also contribute independently to mitochondrial inhibition. In summary, mitochondrial respiration can be inhibited by DA and its metabolites by four distinct MAO‐dependent and independent mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons
Lotharius, J., Dugan, L. L., & O’Malley, K. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01284.1999 · Cited by 403
Shults, C. W., Haas, R. H., Passov, D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410420221 · Cited by 326
Redox-Dependent Modulation of Aconitase Activity in Intact Mitochondria
Bulteau, A.-L., Ikeda-Saito, M., & Szweda, L. I. (2003) · Biochemistry · doi:10.1021/bi0353979 · Cited by 241
Cited by
Oxidative stress and Parkinson’s disease
Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00091 · Cited by 878
“…of the DA transporter (DAT) and the TH enzyme (Kuhn et al., 1999; Whitehead et al., 2001), as well as mitochondrial dysfunction (Lee et al., 2003), alterations of brain mitochondria (Gluck and Zeevalk, 2004) and dysfunction in Complex I activity (Jana et al., 2007, 2011; Van Laar et al., 2009).”
BackgroundLoss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress
Gautier, C. A., Kitada, T., & Shen, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802076105 · Cited by 698
“Thus, the most likely explanation for the striatum specificity of the mitochondrial defects observed in PINK1 / mice is that the striatum receives nigrostriatal dopaminergic projections and contains high concentrations of dopamine, which can degrade into cytotoxic oxyradicals and inhibit pyruvate/malate respiration (3…”
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Redox imbalance in Parkinson's disease
Chinta, S. J., & Andersen, J. K. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.02.005 · Cited by 302
Healthy aging and muscle function are positively associated with NAD+ abundance in humans
Janssens, G. E., Grevendonk, L., Perez, R. Z., Schomakers, B. V., de Vogel-van den Bosch, J., Geurts, J. M. W., van Weeghel, M., Schrauwen, P., Houtkooper, R. H., & Hoeks, J. (2022) · Nature Aging · doi:10.1038/s43587-022-00174-3 · Cited by 103
Metadata
- Authors
- Gluck, M. R., & Zeevalk, G. D.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2004-10-27
- Volume
- 91
- Issue
- 4
- Pages
- 788-795
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2047791683
- Cited by
- 96
- References
- 5
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine‐associated diseases. https://app.cochat.ai/papers/10.1111/j.1471-4159.2004.02747.x
- The paper
- Gluck, M. R., & Zeevalk, G. D. (2004). Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine‐associated diseases. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2004.02747.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.